Search research articles
Contact Us
Filters
Showing results (171-180 of 188) with videos related to
Page
of 19
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 24, 2018
Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease
Hubert H Fernandez, James T Boyd, Victor S C Fung, et al.
Parkinsonism & Related Disorders
|
October 25, 2021
Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications
Angelo Antonini, Per Odin, Peter Schmidt, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
October 12, 2012
CD4+ regulatory and effector/memory T cell subsets profile motor dysfunction in Parkinson's disease
Jessica A Hutter Saunders, Katherine A Estes, Lisa M Kosloski, et al.
The Lancet. Neurology
|
November 19, 2022
Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial
Michael J Soileau, Jason Aldred, Kumar Budur, et al.
Journal of Parkinson'S Disease
|
January 21, 2020
Comparison of an Online-Only Parkinson's Disease Research Cohort to Cohorts Assessed In Person
Lana M Chahine, Iris Chin, Chelsea Caspell-Garcia, et al.
Acta Neuropathologica
|
June 28, 2006
No alteration in tau exon 10 alternative splicing in tangle-bearing neurons of the Alzheimer's disease brain
Martin Ingelsson, Karunya Ramasamy, Ippolita Cantuti-Castelvetri, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 30, 2014
Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: final 12-month, open-label results
Hubert H Fernandez, David G Standaert, Robert A Hauser, et al.
NPJ Parkinson'S Disease
|
June 27, 2017
Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson's disease trial
Howard E Gendelman, Yuning Zhang, Pamela Santamaria, et al.
NPJ Parkinson'S Disease
|
March 2, 2021
The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism
Caroline M Tanner, Steven R Cummings, Michael A Schwarzschild, et al.
Human Molecular Genetics
|
July 27, 2013
LRRK2 secretion in exosomes is regulated by 14-3-3
Kyle B Fraser, Mark S Moehle, João P L Daher, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 188) with videos related to
Sort By:
Page
of 19
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 24, 2018
Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease
Hubert H Fernandez, James T Boyd, Victor S C Fung, et al.
Parkinsonism & Related Disorders
|
October 25, 2021
Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications
Angelo Antonini, Per Odin, Peter Schmidt, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
October 12, 2012
CD4+ regulatory and effector/memory T cell subsets profile motor dysfunction in Parkinson's disease
Jessica A Hutter Saunders, Katherine A Estes, Lisa M Kosloski, et al.
The Lancet. Neurology
|
November 19, 2022
Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial
Michael J Soileau, Jason Aldred, Kumar Budur, et al.
Journal of Parkinson'S Disease
|
January 21, 2020
Comparison of an Online-Only Parkinson's Disease Research Cohort to Cohorts Assessed In Person
Lana M Chahine, Iris Chin, Chelsea Caspell-Garcia, et al.
Acta Neuropathologica
|
June 28, 2006
No alteration in tau exon 10 alternative splicing in tangle-bearing neurons of the Alzheimer's disease brain
Martin Ingelsson, Karunya Ramasamy, Ippolita Cantuti-Castelvetri, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 30, 2014
Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: final 12-month, open-label results
Hubert H Fernandez, David G Standaert, Robert A Hauser, et al.
NPJ Parkinson'S Disease
|
June 27, 2017
Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson's disease trial
Howard E Gendelman, Yuning Zhang, Pamela Santamaria, et al.
NPJ Parkinson'S Disease
|
March 2, 2021
The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism
Caroline M Tanner, Steven R Cummings, Michael A Schwarzschild, et al.
Human Molecular Genetics
|
July 27, 2013
LRRK2 secretion in exosomes is regulated by 14-3-3
Kyle B Fraser, Mark S Moehle, João P L Daher, et al.
Page
of 19